NeuroSigma Announces MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to...
The RepTrak Company Announces Acquisition of Checkmate Capital Advised ESG AnalyticsMarch 7, 2022 - Boston, MA - The RepTrak Company, the world’s leading reputation data and insights company, today announced the...
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA...